Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer

NCT05378919 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX

Interventions

RADIATION: Radiotherapy 50 Gy
DRUG: Fluorouracil/folic acid
DRUG: Chemotherapy in regimen with Oxaliplatin, fluorouracil, folinic acid (FOLFOX4)
RADIATION: Radiotherapy 50 Gy

Sponsor

Lithuanian University of Health Sciences